Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
17 05 2019
Historique:
received: 02 11 2018
accepted: 17 04 2019
entrez: 18 5 2019
pubmed: 18 5 2019
medline: 18 12 2019
Statut: ppublish

Résumé

The ATP-binding cassette subfamily B member 1 (ABCB1) multidrug transporter P-glycoprotein plays a central role in clearance of xenobiotics in humans and is implicated in cancer resistance to chemotherapy. We used double electron electron resonance spectroscopy to uncover the basis of stimulation of P-glycoprotein adenosine 5'-triphosphate (ATP) hydrolysis by multiple substrates and illuminate how substrates and inhibitors differentially affect its transport function. Our results reveal that substrate-induced acceleration of ATP hydrolysis correlates with stabilization of a high-energy, post-ATP hydrolysis state characterized by structurally asymmetric nucleotide-binding sites. By contrast, this state is destabilized in the substrate-free cycle and by high-affinity inhibitors in favor of structurally symmetric nucleotide binding sites. Together with previous data, our findings lead to a general model of substrate and inhibitor coupling to P-glycoprotein.

Identifiants

pubmed: 31097669
pii: 364/6441/689
doi: 10.1126/science.aav9406
pmc: PMC6890515
mid: NIHMS1060216
doi:

Substances chimiques

ABCB1 protein, human 0
ATP Binding Cassette Transporter, Subfamily B 0
Dibenzocycloheptenes 0
Quinolines 0
zosuquidar trihydrochloride 813AGY3126
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

689-692

Subventions

Organisme : NIGMS NIH HHS
ID : U54 GM087519
Pays : United States

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Nature. 2017 Jun 22;546(7659):504-509
pubmed: 28554189
Biochem Pharmacol. 2016 Feb 1;101:40-53
pubmed: 26686578
Science. 2018 Feb 23;359(6378):915-919
pubmed: 29371429
J Biol Chem. 2003 Jul 18;278(29):26862-9
pubmed: 12746444
FEBS Lett. 2006 Feb 13;580(4):1049-55
pubmed: 16412422
Biochem Pharmacol. 2014 Dec 15;92(4):558-66
pubmed: 25456855
J Am Chem Soc. 2018 Apr 4;140(13):4527-4533
pubmed: 29308886
J Biol Chem. 2017 Jan 13;292(2):446-461
pubmed: 27864369
Methods Enzymol. 2015;563:531-67
pubmed: 26478498
Structure. 2011 Nov 9;19(11):1549-61
pubmed: 22078555
Cell. 2017 Mar 9;168(6):1075-1085.e9
pubmed: 28238471
J Biol Chem. 2017 Apr 28;292(17):7066-7076
pubmed: 28283574
J Bioenerg Biomembr. 2005 Dec;37(6):497-500
pubmed: 16691489
Mol Pharmacol. 1994 Apr;45(4):763-72
pubmed: 7910372
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E1973-E1982
pubmed: 29440498
Nature. 2017 Mar 30;543(7647):738-741
pubmed: 28289287
Nat Rev Mol Cell Biol. 2009 Mar;10(3):218-27
pubmed: 19234479
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15152-6
pubmed: 21825153
Biophys J. 2018 Oct 2;115(7):1200-1216
pubmed: 30197182
Annu Rev Phys Chem. 2012;63:419-46
pubmed: 22404592
Phys Chem Chem Phys. 2007 Apr 28;9(16):1895-910
pubmed: 17431518
Pharmacogenomics. 2008 Jan;9(1):105-27
pubmed: 18154452
J Biol Chem. 2003 Dec 26;278(52):52629-40
pubmed: 14551217
Elife. 2014 May 16;3:e02740
pubmed: 24837547
Biochim Biophys Acta Biomembr. 2018 Apr;1860(4):818-832
pubmed: 29097275
Biochemistry. 2008 Mar 11;47(10):3294-307
pubmed: 18275155
Biophys J. 2010 Mar 17;98(6):L18-20
pubmed: 20303847
J Biol Chem. 1995 Nov 10;270(45):26956-61
pubmed: 7592942
Q Rev Biophys. 2007 Feb;40(1):1-53
pubmed: 17565764
J Biol Chem. 2009 May 15;284(20):13904-13
pubmed: 19278995
Nat Struct Mol Biol. 2016 Jun 7;23(6):487-93
pubmed: 27273632
J Biol Chem. 2017 Dec 15;292(50):20412-20424
pubmed: 29018094
J Biol Chem. 2010 Mar 5;285(10):7575-86
pubmed: 20061384
Protein Sci. 2014 Jan;23(1):34-46
pubmed: 24155053
Phys Chem Chem Phys. 2011 Feb 14;13(6):2356-66
pubmed: 21116569

Auteurs

Reza Dastvan (R)

Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232, USA.

Smriti Mishra (S)

Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232, USA.

Yelena B Peskova (YB)

Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22908, USA.

Robert K Nakamoto (RK)

Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22908, USA.

Hassane S Mchaourab (HS)

Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232, USA. hassane.mchaourab@vanderbilt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH